Objective: Chronic inflammation of adipose tissues contributes to obesity-triggered insulin resistance. Unfortunately, the potential molecular mechanisms regarding obesity-associated systemic inflammation and metabolic disorder remain complicated. Here, we report that inactive rhomboid-like protein 2 (iRhom2) was increased in overweight mice with adipose inflammation.
Methods: Mice with deletion of iRhom2 on a C57BL/6J background, mice without deletion of this gene (controls), and mice with deficiency of iRhom2 only in myeloid cells were fed a standard chow diet (SCD) or a high-fat diet (HFD; 60% fat calories). Then the adipose tissues or bone marrow cells were isolated for the further detection.
Results: After 16 weeks on a high-fat diet (HFD), obesity, chronic inflammation in adipose tissues, and insulin resistance were markedly mitigated in iRhom2 knockout (iRhom2 KO) mice, whereas these parameters were exaggerated in iRhom2 overactivated mice. The adverse influences of iRhom2 on adipose inflammation and associated pathologies were determined in db/db mice. We further demonstrated that, in response to an HFD, iRhom2 KO mice and mice with deletion only in the myeloid cells showed less severe adipose inflammation and insulin resistance than control groups. Conversely, transplantation of bone marrow cells from normal mice to iRhom2 KO mice unleashed severe systemic inflammation and metabolic dysfunction after HFD ingestion.
Conclusion: We identified iRhom2 as a key regulator that promotes obesity-associated metabolic disorders. Loss of iRhom2 from macrophages in adipose tissues may indirectly restrain inflammation and insulin resistance via blocking crosslinks between macrophages and adipocytes. Hence, iRhom2 may be a therapeutic target for obesity-induced metabolic dysfunction.
Keywords: Adipose inflammation; Dyslipidemia; Insulin resistance; iRhom2.
Copyright © 2020. Published by Elsevier GmbH.
Loss of iRhom2 accelerates fat gain and insulin resistance in diet-induced obesity despite reduced adipose tissue inflammation.Metabolism. 2020 May;106:154194. doi: 10.1016/j.metabol.2020.154194. Epub 2020 Mar 2. Metabolism. 2020. PMID: 32135161
Endoplasmic reticulum stress-induced iRhom2 up-regulation promotes macrophage-regulated cardiac inflammation and lipid deposition in high fat diet (HFD)-challenged mice: Intervention of fisetin and metformin.Free Radic Biol Med. 2019 Sep;141:67-83. doi: 10.1016/j.freeradbiomed.2019.05.031. Epub 2019 May 30. Free Radic Biol Med. 2019. PMID: 31153974
Spred2 Regulates High Fat Diet-Induced Adipose Tissue Inflammation, and Metabolic Abnormalities in Mice.Front Immunol. 2019 Jan 22;10:17. doi: 10.3389/fimmu.2019.00017. eCollection 2019. Front Immunol. 2019. PMID: 30723473 Free PMC article.
Deletion of iRhom2 protects against diet-induced obesity by increasing thermogenesis.Mol Metab. 2020 Jan;31:67-84. doi: 10.1016/j.molmet.2019.10.006. Epub 2019 Oct 31. Mol Metab. 2020. PMID: 31918923 Free PMC article.
Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance.Biochim Biophys Acta. 2014 Mar;1842(3):446-62. doi: 10.1016/j.bbadis.2013.05.017. Epub 2013 May 22. Biochim Biophys Acta. 2014. PMID: 23707515 Free PMC article. Review.
- Heymsfield S.B., Wadden T.A. Mechanisms, pathophysiology, and management of obesity. New England Journal of Medicine. 2017;376(3):254–266. - PubMed
- Reilly S.M., Saltiel A.R. Adapting to obesity with adipose tissue inflammation. Nature Reviews Endocrinology. 2017;13(11):633. - PubMed
- Lackey D.E., Olefsky J.M. Regulation of metabolism by the innate immune system. Nature Reviews Endocrinology. 2016;12(1):15. - PubMed